These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


270 related items for PubMed ID: 1762117

  • 1. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
    Otake M, Schull WJ.
    J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
    [Abstract] [Full Text] [Related]

  • 2. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M, Schull WJ.
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [Abstract] [Full Text] [Related]

  • 3. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y, Kato H, Schull WJ, Preston DL, Fujita S, Pierce DA.
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [Abstract] [Full Text] [Related]

  • 4. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation.
    Otake M, Neriishi K, Schull WJ.
    Radiat Res; 1996 Sep; 146(3):339-48. PubMed ID: 8752314
    [Abstract] [Full Text] [Related]

  • 5. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M, Schull WJ.
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract] [Full Text] [Related]

  • 6. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W, Walsh L, Chomentowski M.
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [Abstract] [Full Text] [Related]

  • 7. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N, Charles MW.
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [Abstract] [Full Text] [Related]

  • 8. Radiation-related ophthalmological changes and aging among Hiroshima and Nagasaki A-bomb survivors: a reanalysis.
    Otake M, Finch SC, Choshi K, Takaku I, Mishima H, Takase T.
    Radiat Res; 1992 Sep; 131(3):315-24. PubMed ID: 1438690
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
    Stram DO, Mizuno S.
    Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
    [Abstract] [Full Text] [Related]

  • 10. Thermoluminescence dosimetry of gamma rays using ceramic samples from Hiroshima and Nagasaki: a comparison with DS86 estimates.
    Nagatomo T, Ichikawa Y, Hoshi M.
    J Radiat Res; 1991 Mar; 32 Suppl():48-57. PubMed ID: 1762131
    [Abstract] [Full Text] [Related]

  • 11. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T.
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [Abstract] [Full Text] [Related]

  • 12. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
    Little MP, Muirhead CR.
    Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
    [Abstract] [Full Text] [Related]

  • 13. Estimation of radiation doses for atomic-bomb survivors in the Hiroshima University Registry.
    Hoshi M, Matsuura M, Hayakawa N, Ito C, Kamada N.
    Health Phys; 1996 May; 70(5):735-40. PubMed ID: 8690587
    [Abstract] [Full Text] [Related]

  • 14. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
    Kellerer AM, Nekolla E.
    Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
    [Abstract] [Full Text] [Related]

  • 15. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
    Little MP.
    Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
    [Abstract] [Full Text] [Related]

  • 16. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA.
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [Abstract] [Full Text] [Related]

  • 17. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ.
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [Abstract] [Full Text] [Related]

  • 18. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
    Cordova KA, Cullings HM.
    Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.